EGFR and osteosarcoma: Moreover, in osteosarcoma cells, circ-ITCH could promote epidermal growth factor receptor (EGFR) protein levels by activating the EGFR/ERK pathway via miR-7 to promote cancer metastasis, migration, and invasion [62].